Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free NAMSW Stock Alerts

NewAmsterdam Pharma (NAMSW) Competitors

NewAmsterdam Pharma logo
$21.31 -3.59 (-14.42%)
As of 06/4/2026 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NAMSW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy NewAmsterdam Pharma stock or one of its competitors? MarketBeat compares NewAmsterdam Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NewAmsterdam Pharma include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does NewAmsterdam Pharma compare to 60 Degrees Pharmaceuticals?

NewAmsterdam Pharma (NASDAQ:NAMSW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Company Net Margins Return on Equity Return on Assets
NewAmsterdam PharmaN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

In the previous week, NewAmsterdam Pharma and NewAmsterdam Pharma both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 0.94 beat NewAmsterdam Pharma's score of 0.93 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NewAmsterdam Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

NewAmsterdam Pharma and 60 Degrees Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Alpha Tau Medical?

NewAmsterdam Pharma (NASDAQ:NAMSW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
NewAmsterdam PharmaN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

In the previous week, NewAmsterdam Pharma had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 1 mentions for NewAmsterdam Pharma and 0 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.87 beat NewAmsterdam Pharma's score of 0.93 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
NewAmsterdam Pharma Positive
Alpha Tau Medical Very Positive

Summary

NewAmsterdam Pharma beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Apollomics?

Apollomics (NASDAQ:APLMW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

In the previous week, NewAmsterdam Pharma had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for NewAmsterdam Pharma and 0 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat NewAmsterdam Pharma's score of 0.93 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
NewAmsterdam Pharma Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

Summary

NewAmsterdam Pharma beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to BioVie?

NewAmsterdam Pharma (NASDAQ:NAMSW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
NewAmsterdam PharmaN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, NewAmsterdam Pharma had 1 more articles in the media than BioVie. MarketBeat recorded 1 mentions for NewAmsterdam Pharma and 0 mentions for BioVie. BioVie's average media sentiment score of 1.89 beat NewAmsterdam Pharma's score of 0.93 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
NewAmsterdam Pharma Positive
BioVie Very Positive

Summary

NewAmsterdam Pharma beats BioVie on 2 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

In the previous week, NewAmsterdam Pharma had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for NewAmsterdam Pharma and 0 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.87 beat NewAmsterdam Pharma's score of 0.93 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Very Positive
NewAmsterdam Pharma Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

Summary

NewAmsterdam Pharma beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

Get NewAmsterdam Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAMSW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAMSW vs. The Competition

Export
MetricNewAmsterdam PharmaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$375.73M$6.30B$12.44B
Dividend YieldN/A3.87%2.69%5.32%
P/E RatioN/A3.2023.7424.34
Price / SalesN/A6,690.20498.0394.98
Price / CashN/A13.1341.3955.53
Price / BookN/A85.7710.046.72
Net IncomeN/A-$96.07M$3.56B$337.03M
7 Day Performance-10.99%-0.91%-1.04%-0.16%
1 Month Performance0.38%2.00%2.18%3.74%
1 Year Performance120.37%75.62%28.95%34.34%

NewAmsterdam Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAMSW
NewAmsterdam Pharma
N/A$21.31
-14.4%		N/A+122.4%$0.00$22.57MN/A29
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-11.2%		N/A-35.3%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.56
+3.6%		N/A+934.9%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
-1.4%		N/A-36.2%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.31
-6.1%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NAMSW) was last updated on 6/5/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel